Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Down 4.5% - Here's Why

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) fell 4.5% during trading on Wednesday . The stock traded as low as $0.79 and last traded at $0.79. 613,793 shares traded hands during trading, a decline of 2% from the average session volume of 624,301 shares. The stock had previously closed at $0.83.

Curaleaf Stock Performance

The stock has a market cap of $530.73 million, a P/E ratio of -2.58 and a beta of 0.59. The company has a fifty day moving average price of $0.87 and a 200 day moving average price of $1.15. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.41 and a quick ratio of 0.70.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. On average, equities analysts expect that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Recommended Stories

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines